Iterum Therapeutics plc (ITRMF) Convertible Debt (2023)

Iterum Therapeutics has reported Convertible Debt for 1 years, with the latest figure at $11.5 million in Q4 2023.

• On a quarterly basis, Convertible Debt changed N/A year-over-year to $11.5 million in Q4 2023; TTM through Dec 2023 was $11.5 million, a N/A change from a year earlier, with the FY2023 full-year figure at $11.5 million, changed N/A from the prior year.
• Convertible Debt was $11.5 million for Q4 2023 at Iterum Therapeutics.
• The five-year high for Convertible Debt was $11.5 million in Q4 2023, with the low at $11.5 million in Q4 2023.